Steven A. Shoemaker

1.2k total citations
24 papers, 960 citations indexed

About

Steven A. Shoemaker is a scholar working on Physiology, Anesthesiology and Pain Medicine and Pharmacology. According to data from OpenAlex, Steven A. Shoemaker has authored 24 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Anesthesiology and Pain Medicine and 6 papers in Pharmacology. Recurrent topics in Steven A. Shoemaker's work include Pain Management and Opioid Use (7 papers), Pain Mechanisms and Treatments (7 papers) and Musculoskeletal pain and rehabilitation (5 papers). Steven A. Shoemaker is often cited by papers focused on Pain Management and Opioid Use (7 papers), Pain Mechanisms and Treatments (7 papers) and Musculoskeletal pain and rehabilitation (5 papers). Steven A. Shoemaker collaborates with scholars based in United States and South Africa. Steven A. Shoemaker's co-authors include D. de Wit, Mitchell L. Sogin, Lafras M. Steyn, Russell K. Portenoy, Daniel Bruns, Daniel S. Bennett, Charles H. Scoggin, Donald R. Taylor, Steven Simon and Ivan F. McMurtry and has published in prestigious journals such as Nature, Journal of Clinical Investigation and CHEST Journal.

In The Last Decade

Steven A. Shoemaker

23 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven A. Shoemaker United States 14 254 238 226 221 211 24 960
John F. Flanagan United States 16 99 0.4× 89 0.4× 30 0.1× 165 0.7× 114 0.5× 35 1.3k
Michelle Goldsworthy United Kingdom 19 31 0.1× 176 0.7× 125 0.6× 202 0.9× 20 0.1× 34 1.5k
Junnan Wang China 15 154 0.6× 118 0.5× 12 0.1× 65 0.3× 106 0.5× 29 788
K Saitoh Japan 17 167 0.7× 76 0.3× 23 0.1× 28 0.1× 14 0.1× 61 1.1k
Franziska M. Konrad Germany 19 17 0.1× 90 0.4× 20 0.1× 277 1.3× 273 1.3× 42 929
David O’Donnell United States 14 12 0.0× 121 0.5× 37 0.2× 66 0.3× 74 0.4× 24 1.1k
Naris Thengchaisri Thailand 13 33 0.1× 347 1.5× 22 0.1× 61 0.3× 41 0.2× 69 765
C Simard United States 7 15 0.1× 203 0.9× 77 0.3× 113 0.5× 33 0.2× 22 1.9k
David F. Dean United States 11 51 0.2× 13 0.1× 41 0.2× 78 0.4× 118 0.6× 21 444
Mark J. Cowan United States 16 22 0.1× 106 0.4× 12 0.1× 144 0.7× 125 0.6× 34 851

Countries citing papers authored by Steven A. Shoemaker

Since Specialization
Citations

This map shows the geographic impact of Steven A. Shoemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven A. Shoemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven A. Shoemaker more than expected).

Fields of papers citing papers by Steven A. Shoemaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven A. Shoemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven A. Shoemaker. The network helps show where Steven A. Shoemaker may publish in the future.

Co-authorship network of co-authors of Steven A. Shoemaker

This figure shows the co-authorship network connecting the top 25 collaborators of Steven A. Shoemaker. A scholar is included among the top collaborators of Steven A. Shoemaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven A. Shoemaker. Steven A. Shoemaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donaldson, Scott H., George M. Solomon, Pamela L. Zeitlin, et al.. (2017). Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR. Journal of Cystic Fibrosis. 16(3). 371–379. 44 indexed citations
2.
Portenoy, Russell K., et al.. (2011). Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, Part 1: Prevalence and characteristics. Journal of Opioid Management. 6(2). 97–108. 64 indexed citations
3.
Portenoy, Russell K., et al.. (2011). Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, Part 2: Impact on function, mood, and quality of life. Journal of Opioid Management. 6(2). 109–116. 44 indexed citations
5.
Bennett, Daniel S., et al.. (2007). Prevalence and characteristics of breakthrough pain in patients receiving opioids for chronic back pain in pain specialty clinics. Journal of Opioid Management. 3(2). 101–106. 17 indexed citations
6.
Bennett, Daniel S., et al.. (2006). Breakthrough pain in opioid-treated patients with neuropathic pain. Journal of Opioid Management. 2(6). 347–352. 5 indexed citations
7.
Portenoy, Russell K., Daniel S. Bennett, Richard Rauck, et al.. (2006). Prevalence and Characteristics of Breakthrough Pain in Opioid-Treated Patients With Chronic Noncancer Pain. Journal of Pain. 7(8). 583–591. 97 indexed citations
8.
Portenoy, R., et al.. (2005). Prevalence and characteristics of breakthrough pain in patients with chronic noncancer pain. Journal of Pain. 6(3). S33–S33. 1 indexed citations
9.
Bruns, Daniel, John Mark Disorbio, Damien Bennett, et al.. (2005). Degree of pain intolerance and adverse outcomes in chronic non-cancer pain patients. Journal of Pain. 6(3). S74–S74. 2 indexed citations
10.
Looker, Douglas L., Steven L. Durfee, Stephen J. Hoffman, et al.. (1992). A human recombinant haemoglobin designed for use as a blood substitute. Nature. 356(6366). 258–260. 224 indexed citations
11.
Wit, D. de, Lafras M. Steyn, Steven A. Shoemaker, & Mitchell L. Sogin. (1990). Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification. Journal of Clinical Microbiology. 28(11). 2437–2441. 187 indexed citations
12.
Shoemaker, Steven A. & Charles H. Scoggin. (1987). DNA Molecular Biology in the Diagnosis of Pulmonary Disease. Clinics in Chest Medicine. 8(1). 161–171. 1 indexed citations
13.
Shoemaker, Steven A.. (1986). Using DNA Hybridization Techniques to Diagnose Infectious Diseases. Seminars in Respiratory and Critical Care Medicine. 7(4). 369–373. 1 indexed citations
14.
Shoemaker, Steven A., James H. Fisher, Wilbur Devereux Jones, & Charles H. Scoggin. (1986). Restriction fragment analysis of chromosomal DNA defines different strains of Mycobacterium tuberculosis.. PubMed. 134(2). 210–3. 29 indexed citations
15.
Scoggin, Charles H., et al.. (1985). The E7-associated cell-surface antigen: a marker for the 11p13 chromosomal deletion associated with aniridia-Wilms tumor.. PubMed. 37(5). 883–9. 4 indexed citations
16.
Shoemaker, Steven A., John E. Heffner, Robert M. Tate, et al.. (1984). Staphylococcus aureus and human platelets cause pulmonary hypertension and thromboxane generation in isolated saline-perfused rabbit lungs.. PubMed. 129(1). 92–5. 4 indexed citations
17.
Heffner, John E., Steven A. Shoemaker, Mitul Patel, et al.. (1983). Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.. Journal of Clinical Investigation. 71(2). 351–357. 95 indexed citations
18.
Heffner, John E., Steven A. Shoemaker, Mahesh Patel, et al.. (1983). Platelet-Induced Pulmonary Hypertension and Edema. CHEST Journal. 83(5). 78S–79S. 4 indexed citations
19.
Shoemaker, Steven A., et al.. (1983). Mepacrine but not Methylprednisolone Decreases Acute Edematous Lung Injury after Injection of Phorbol Myristate Acetate in Rabbits 1, 2. American Review of Respiratory Disease. 127(5). 594–598. 13 indexed citations
20.
Heffner, John E., Steven A. Shoemaker, Mahesh Patel, et al.. (1983). Platelet-induced pulmonary hypertension and edema. A mechanism involving acetyl glyceryl ether phosphorylcholine and thromboxane A2.. PubMed. 83(5 Suppl). 78S–79S. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026